Intrathecal @entity1772 : Its effect on symptoms and activities of daily living in severe XXXX due to @entity1566 : A pilot study.

@entity1 @entity508 @entity2473 @entity158 @entity1566 @entity1772 @entity25
BACKGROUND: Spasticity is a major problem related to @entity1566 . Use of intrathecal @entity1772 with an implanted pump seems a very useful mode of therapy in @entity1 in whom oral antispasmodic agents are either not effective or produce intolerable side-effects. MATERIALS AND METHODS: Twenty-four @entity1 with mean age 50 years (range 32-72 years) had intrathecal @entity1772 pump implanted for the severe @entity508 of spinal origin. One @entity1 died following implantation of pump due to natural causes and was not included in the study. The @entity1 were followed up for mean 22 months (range, one to five years). RESULTS: All 24 @entity1 showed improvement in their @entity2473 following the procedure. Improvement was noted in @entity158 (12), @entity25 (20) and sphincter control (14). @entity1 had improvement in activities of daily living such as feeding ability (10), self care (10), indoor and outdoor mobility (19), and driving (4). One @entity1 had catheter leakage immediately after the surgery and required change of catheter. The radio telemetry allows very good adjustment of the dose according the individual @entity1 needs. CONCLUSION: Intrathecal @entity1772 pump improves the symptoms of @entity2473 and also the quality of life. It helps the @entity1 to live more independently. It is not an irreversible surgery for the @entity1 and hence it is very useful in the changing the dynamics in this group of @entity1 .
